The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tarsus Pharmaceuticals Inc shares valued at $550,035 were sold by Farrow Jeffrey S on Jun 17 ’25. At $40.42 per share, Farrow Jeffrey S sold 13,608 shares. The insider’s holdings dropped to 36,704 shares worth approximately $1.51 million following the completion of this transaction.
Also, Farrow Jeffrey S purchased 13,608 shares, netting a total of over 550,088 in proceeds.
Before that, Lin Elizabeth Yeu had sold 1,006 shares from its account. In a trade valued at $41,326, the Chief Medical Officer traded Tarsus Pharmaceuticals Inc shares for $41.08 each. Upon closing the transaction, the insider’s holdings decreased to 1,006 shares, worth approximately $0.32 million.
As of November 20, 2023, Goldman has initiated its “Neutral” rating for TARS. Earlier on July 18, 2023, William Blair initiated its rating. Their recommendation was “an Outperform” for TARS stock.
Analyzing TARS Stock Performance
On last trading session,, Tarsus Pharmaceuticals Inc [NASDAQ: TARS] plunged -0.31% to $41.16. The stock’s lowest price that day was $40.69, but it reached a high of $41.7 in the same session. During the last five days, there has been a surge of approximately 1.76%. Over the course of the year, Tarsus Pharmaceuticals Inc shares have jumped approximately 45.54%. Shares of the company reached a 52-week high of $57.28 on 02/05/25 and a 52-week low of $38.51 on 07/08/25.
Support And Resistance Levels for Tarsus Pharmaceuticals Inc (TARS)
According to the 24-hour chart, there is a support level at 40.66, which, if violated, would cause prices to drop to 40.16. In the upper region, resistance lies at 41.69. The next price resistance is at 42.22. RSI (Relative Strength Index) is 48.55 on the 14-day chart, showing neutral technical sentiment.
Is Tarsus Pharmaceuticals Inc subject to short interest?
Stocks of Tarsus Pharmaceuticals Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.33 million shares to 8.11 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 7.78 million shares. A jump of 4.09% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.97 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.97.
Which companies own the most shares of Tarsus Pharmaceuticals Inc (TARS)?
#####
In terms of Tarsus Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 67 in the next 12 months, up nearly 62.27% from the previous closing price of $41.29. Analysts anticipate Tarsus Pharmaceuticals Inc stock to reach 84 by 2025, with the lowest price target being 58. In spite of this, 4 analysts ranked Tarsus Pharmaceuticals Inc stock as Buy at the end of 2025.
